Title : The use of stereotactic body radiation therapy in patients with severe COPD
Non-small cell lung cancer (NSCLC) is one of the most common cancers worldwide and has a strong link to smoking, as does the development of COPD. Because of poor respiratory reserves, these patients are often not candidates for definitive surgery. SBRT represents an excellent alternative for patients who have clinically node-negative lung cancer and small primary tumors. This talk will focus on data surrounding the criteria for surgical resection of early-stage lung cancers and the data for SBRT in patients with severe COPD, changes in lung function, and the persistent benefit of treatment even in very elderly, comorbid patients. The talk will highlight the logistics of treatment and anticipated outcomes.